Use access key #2 to skip to page content.
$15.74 -1.51 (-8.75%)
1/7/2009 11:50 AM

Abaxis, Inc. (ABAX)

CAPS Rating:
***

The Company develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.

View All Commentary (ABAX)

Recs

0

Avatar JFiege (31.81) Submitted: 11/07/07 4:47 PM : Outperform Start Price: $32.40 ABAX Score: -13.38

Abax is improving product and has great potential in the human market, which is 6-8 times the size of the veterinarian market. The FDA is going to allow their blood testing machines into the human market soon, most likely, and that has very strong potential. The P/E today is rather high, in the 60s, but I believe the potential warrants the price. Good luck.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links